NDA Partners, A ProPharma Company.
Dr. Beary’s clinical expertise in rheumatology and immunology, in addition to his extensive knowledge of product development and regulation will be a valuable resource to companies developing new therapies in these areas.
WASHINGTON (PRWEB)
April 06, 2023
NDA Partners’ Vice President and General Manager, Eric Fish, announced today that Dr. John Beary, an experienced clinical rheumatologist with more than 30 years of experience in clinical drug development and regulation, has joined the firm as an Expert Consultant. Dr. Beary’s expertise focuses on musculoskeletal/immunology/ rheumatology projects and throughout his career, he has served in academic, industry, and government roles including more than 40 years in clinical rheumatology and academic medicine.
Dr. Beary was formerly Professor of Clinical Medicine, Division of Immunology and Rheumatology with the University of Cincinnati where his research focused on rheumatoid arthritis, osteoporosis, and gout. Prior to this role, he served as Senior Medical Director, Musculoskeletal and Bone Research, Department of Worldwide Clinical Development, Procter & Gamble Pharmaceuticals and Senior Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America. As Senior Vice President of PhRMA, he was responsible for drug policy matters including drug safety, clinical development, and regulatory affairs and was Founding Member of the Steering Committee of the International Conference on Harmonization (ICH), and President of the Pharmaceutical Education and Research Institute (PERI).
Dr. Beary also served as Deputy Assistant Secretary of Defense (Health Affairs), Department of Defense in his early career, where he was responsible for oversight of DOD medical readiness, health benefits, and health information system programs. According to Dr. Carl Peck, Manager of NDA Partners’ drug development practice, “Dr. Beary’s clinical expertise in rheumatology and immunology, in addition to his extensive knowledge of product development and regulation will be a valuable resource to companies developing new therapies in these areas. We are pleased to welcome Dr. Beary to our team of Expert Consultants.”
Dr. Beary received his medical degree from Harvard Medical School, master’s in business administration from Georgetown University, and bachelor’s degree from the University of Notre Dame. He is board certified by American Board of Internal Medicine and completed his internal medicine residency with the Osler Medical Service at Johns Hopkins Hospital and rheumatology fellowship with the Hospital for Special Surgery and Cornell-New York Hospital Medical Center in New York City.
About NDA Partners
NDA Partners, a ProPharma company, is a life sciences management consulting and contract development organization focused on providing product development and regulatory services to the pharmaceutical, biotechnology, and medical device industries worldwide. The highly experienced Expert Consultants in NDA Partners include three former FDA Center Directors; the former Chief Executive Officer and Chief Science Officer at the United States Pharmacopeial Convention (USP); an international team of more than 100 former pharmaceutical industry and regulatory agency senior executives; and an extensive roster of highly proficient experts in specialized areas including nonclinical development, toxicology, pharmacokinetics, CMC, medical device design control and quality systems, clinical development, regulatory submissions, and development program management. Services include product development and regulatory strategy, product development program design and management, expert consulting, functional teams, project-based solutions, and clinical trial design and management.
Contact
Eric Fish, Vice President & General Manager
Office: 540-738-2550
FishEric@ndapartners.com
Share article on social media or email: